JESSICA HICKMAN: Open Payments
NPI 1396235289 · ROSENBERG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,021 in 38 payments from 6 companies in 2025. Trend: 2023 $836 · 2024 $657 · 2025 $1,021
Food & beverage: $1,021
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 6 | $231 |
| Alkermes, Inc. | 7 | $193 |
| Teva Pharmaceuticals USA, Inc. | 7 | $188 |
| Janssen Pharmaceuticals, Inc | 8 | $165 |
| E.R. Squibb & Sons, L.L.C. | 6 | $145 |
| Otsuka America Pharmaceutical, Inc. | 4 | $100 |
Products named: INVEGA SUSTENNA, COBENFY, AUSTEDO XR, LYBALVI, INGREZZA, ABILIFY ASIMTUFII, ARISTADA, UZEDY.
Industry payments across TX — which companies pay providers there.
